UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Model-Based Drug Development: A Rational Approach to Efficiently Accelerate Drug Development

Clinical pharmacology and therapeutics, 2013-06, Vol.93 (6), p.502-514

2013

Volltextzugriff (PDF)

Model‐Based Drug Development: A Rational Approach to Efficiently Accelerate Drug Development

Clinical pharmacology and therapeutics, 2013-06, Vol.93 (6), p.502-514

2013

Volltextzugriff (PDF)

The effect of carbamazepine on the steady‐state pharmacokinetics of ziprasidone in healthy volunteers

British journal of clinical pharmacology, 2000-01, Vol.49 (S1), p.65-70

2000

Volltextzugriff (PDF)

The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function

British journal of clinical pharmacology, 2000-01, Vol.49 (S1), p.27-33

2000

Volltextzugriff (PDF)

Ziprasidone and the pharmacokinetics of a combined oral contraceptive

British journal of clinical pharmacology, 2000-01, Vol.49 (S1), p.49-56

2000

Volltextzugriff (PDF)

Ziprasidone and the activity of cytochrome P450 2D6 in healthy extensive metabolizers

British journal of clinical pharmacology, 2000-01, Vol.49 (S1), p.43-47

2000

Volltextzugriff (PDF)

The effects of ziprasidone on steady‐state lithium levels and renal clearance of lithium

British journal of clinical pharmacology, 2000-01, Vol.49 (S1), p.61-64

2000

Volltextzugriff (PDF)

The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function

British journal of clinical pharmacology, 2000-01, Vol.49 (S1), p.21-26

2000

Volltextzugriff (PDF)

Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: A randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder

Clinical therapeutics, 2010-03, Vol.32 (3), p.472-491

2010

Volltextzugriff (PDF)

The QT interval

Progress in cardiovascular diseases, 2001-04, Vol.43 (5B), p.1-45, Article apcad0430001b

2001

Volltextzugriff (PDF)

The QT interval

Progress in cardiovascular diseases, 2001-03, Vol.43 (5), p.1-45

2001

Volltextzugriff (PDF)

The anxiolytic effect of the novel antipsychotic ziprasidone compared with diazepam in subjects anxious before dental surgery

Journal of clinical psychopharmacology, 2002-04, Vol.22 (2), p.206-210

2002

Volltextzugriff (PDF)

A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition

Journal of clinical psychopharmacology, 2004-02, Vol.24 (1), p.62-69

2004

Volltextzugriff (PDF)

A Trial of Intracranial-Pressure Monitoring in Traumatic Brain Injury

The New England journal of medicine, 2012-12, Vol.367 (26), p.2471-2481

2012

Volltextzugriff (PDF)

584P Tepotinib exposure-response analyses of safety and efficacy in patients with solid tumours

Annals of oncology, 2020-09, Vol.31, p.S494-S495

2020

Volltextzugriff (PDF)

MO01.47 Tepotinib Exposure-Response Analyses of Safety and Efficacy in Patients with Solid Tumors

Journal of thoracic oncology, 2021-01, Vol.16 (1), p.S36-S36

2021

Volltextzugriff (PDF)

Thorough QT Study with Recommended and Supratherapeutic Doses of Tolterodine

Clinical pharmacology and therapeutics, 2007-03, Vol.81 (3), p.377-385

2007

Volltextzugriff (PDF)

Mitochondrial transformation in yeast by bombardment with microprojectiles

Science (American Association for the Advancement of Science), 1988-06, Vol.240 (4858), p.1538-1541

1988

Volltextzugriff (PDF)

Investigating Drug-Induced QT and QTc Prolongation in the Clinic: A Review of Statistical Design and Analysis Considerations: Report from the Pharmaceutical Research and Manufacturers of America QT Statistics Expert Team

Drug information journal, 2005-07, Vol.39 (3), p.243-265

Patterson, Scott D.

2005

Volltextzugriff (PDF)

Smoking Cessation With Varenicline, a Selective α4β2 Nicotinic Receptor Partial Agonist: Results From a 7-Week, Randomized, Placebo- and Bupropion-Controlled Trial With 1-Year Follow-up

Archives of internal medicine (1960), 2006-08, Vol.166 (15), p.1561

Nides, Mitchell

2006

Volltextzugriff (PDF)

Effects of oral ziprasidone and haloperidol on QTC at clinical and high doses

Schizophrenia research, 2003-03, Vol.60 (1), p.314-314

2003

Volltextzugriff (PDF)

The impact of age on risk of adverse drug reactions to digoxin

Journal of clinical epidemiology, 1993-11, Vol.46 (11), p.1305-1314

1993

Volltextzugriff (PDF)

Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up

Archives of internal medicine (1960), 2006-08, Vol.166 (15), p.1561

2006

Volltextzugriff (PDF)

P.2.068 The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function

European neuropsychopharmacology, 1997-09, Vol.7, p.S214-S215

1997

Volltextzugriff (PDF)

P.2.090 The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function

European neuropsychopharmacology, 1997-09, Vol.7, p.S220-S220

1997

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(16)
Life Sciences & Biomedicine
(15)
Humans
(14)
Adult
(12)
Pharmacology & Pharmacy
(12)
Female
(11)
Male
(11)
Biological And Medical Sciences
(10)
Middle Aged
(10)
Medical Sciences
(9)
Adolescent
(7)
Area Under Curve
(6)
Pharmacokinetics
(6)
Pharmacology. Drug Treatments
(6)
Supplement
(6)
Ziprasidone
(6)
Double-Blind Method
(5)
Aged
(4)
Antipsychotic Agents - Adverse Effects
(4)
Antipsychotic Agents - Pharmacokinetics
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Model-Based Drug Development: A Rational Approach to Efficiently Accelerate Drug Development

Model‐Based Drug Development: A Rational Approach to Efficiently Accelerate Drug Development

The effect of carbamazepine on the steady‐state pharmacokinetics of ziprasidone in healthy volunteers

The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function

Ziprasidone and the pharmacokinetics of a combined oral contraceptive

Ziprasidone and the activity of cytochrome P450 2D6 in healthy extensive metabolizers

The effects of ziprasidone on steady‐state lithium levels and renal clearance of lithium

The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function

Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: A randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder

The QT interval

The QT interval

The anxiolytic effect of the novel antipsychotic ziprasidone compared with diazepam in subjects anxious before dental surgery

A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition

A Trial of Intracranial-Pressure Monitoring in Traumatic Brain Injury

584P Tepotinib exposure-response analyses of safety and efficacy in patients with solid tumours

MO01.47 Tepotinib Exposure-Response Analyses of Safety and Efficacy in Patients with Solid Tumors

Thorough QT Study with Recommended and Supratherapeutic Doses of Tolterodine

Mitochondrial transformation in yeast by bombardment with microprojectiles

Investigating Drug-Induced QT and QTc Prolongation in the Clinic: A Review of Statistical Design and Analysis Considerations: Report from the Pharmaceutical Research and Manufacturers of America QT Statistics Expert Team

Smoking Cessation With Varenicline, a Selective α4β2 Nicotinic Receptor Partial Agonist: Results From a 7-Week, Randomized, Placebo- and Bupropion-Controlled Trial With 1-Year Follow-up

Effects of oral ziprasidone and haloperidol on QTC at clinical and high doses

The impact of age on risk of adverse drug reactions to digoxin

Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up

P.2.068 The pharmacokinetics of ziprasidone in subjects with normal and impaired renal function

P.2.090 The pharmacokinetics of ziprasidone in subjects with normal and impaired hepatic function

Suchergebnisse filtern